Ticker: ARKG CUSIP: 00214Q302 Class: GENOMIC REV ETF
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 4,025,965 | $116,632 | — | — |
| Q3 2025 | 2,832,170 | $78,649 | — | — |
| Q2 2025 | 2,126,476 | $51,780 | — | — |
| Q1 2025 | 2,365,014 | $49,098 | — | — |
| Q4 2024 | 3,484,336 | $82,039 | — | — |
| Q3 2024 | 1,413,433 | $36,184 | — | — |
| Q2 2024 | 1,537,640 | $36,104 | — | — |
| Q1 2024 | 1,955,424 | $56,238 | — | — |
| Q4 2023 | 1,599,445 | $52,478 | — | — |
| Q3 2023 | 3,206,979 | $89,346 | — | — |
| Q2 2023 | 3,376,345 | $115,100 | — | — |
| Q1 2023 | 4,167,232 | $125,309 | — | — |
| Q4 2022 | 3,605,714 | $101,789 | — | — |
| Q3 2022 | 4,977,850 | $163,621 | — | — |
| Q2 2022 | 3,434,077 | $108,138 | — | — |
| Q1 2022 | 4,187,534 | $192,333 | — | — |
| Q4 2021 | 3,632,378 | $222,447 | — | — |
| Q3 2021 | 3,740,539 | $279,494 | — | — |
| Q2 2021 | 3,197,205 | $295,741 | — | — |
| Q1 2021 | 3,361,788 | $298,292 | — | — |
| Q4 2020 | 2,578,876 | $240,506 | — | — |
| Q3 2020 | 1,929,902 | $122,954 | — | — |
| Q2 2020 | 1,507,896 | $78,652 | — | — |
| Q1 2020 | 1,161,567 | $36,334 | — | — |
| Q4 2019 | 816,741 | $27,377 | — | — |
| Q3 2019 | 660,837 | $19,508 | — | — |
| Q2 2019 | 607,457 | $20,939 | — | — |
| Q1 2019 | 540,908 | $17,785 | — | — |
| Q4 2018 | 471,886 | $11,316 | — | — |
| Q3 2018 | 524,698 | $17,541 | — | — |
| Q2 2018 | 382,243 | $11,108 | — | — |
| Q1 2018 | 252,200 | $6,494 | — | — |
| Q4 2017 | 89,083 | $2,181 | — | — |
| Q3 2017 | 33,497 | $879 | — | — |
| Q2 2017 | 26 | $1 | — | — |